The main purpose of this study is to compare the amount of LY3871801 that gets into the blood
stream and how long it takes the body to get rid of it, when given as crystalline freebase
tablet (test) and as a solid dispersion oral suspension (reference) in healthy participants.
The information about any adverse effects experienced will be collected and the tolerability
of LY3871801 will also be evaluated. The study may last up to approximately 15 days excluding
the 28 days of screening period.
A Drug Interaction Study of LY3871801 in Healthy Participants
Not yet recruiting
Eli Lilly and Company
Phase 1
The main purpose of this study is to determine the effect of LY3871801 when administered
orally on the levels of methotrexate (part 1), drug cocktail (warfarin, dextromethorphan, and
midazolam) and repaglinide (part 2) in the blood stream when administered orally in healthy
participants. The information about any adverse effects experienced will be collected and the
tolerability of LY3871801 will also be evaluated. The study may last up to approximately 25
days for each participant.
An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis
Not yet recruiting
Rigel Pharmaceuticals
Phase 2
The main purpose of this study is to evaluate the efficacy and safety of LY3871801 in adult
participants with active moderately-to-severe rheumatoid arthritis (RA).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
